אופלוקסצינה - Ofloxacina

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)

J01MA
Fluoroquinolones

××¨××× ×¤×¢×× (ATC5)

Ofloxacin AS HYDROCHLORIDE 2MG/ML âJ01MA01

×¦××¨×ª ××ª×

×ª××-××¨××× - I.V

×¦××¨×ª ××× ××

×ª×××¡× ×××× ×¤××××, SOLUTION FOR INFUSION
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Infections of kidney, urinarty tract, genital organs, respiratory tract, chronic and recurrent ear, nose and throat, skin and soft tissues, bones and joints, bacterial enteritis, abdominal cavity, including pelvis minor and septicemia caused by ofloxacin sensitive microorganisms. Prevention of infections in patients with a signifcant reduction of resistance to infections.

× ×ª×× × ×¡× [ ××¦×× ]

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

×©××××© ××¡×

Urogenital, respiratory and gastrointestinal infections caused by gram-negative pathogens including: e. coli, citrobacter, klebsiella, enterobacter, proteus, acinetobacter, pseudomonas aeruginosa, chlamydia, gonococcus, campylobacter, salmonella & shigella. gram positive organisms: staphylococcus aureus & epidermidis & group D streptococci.

×ª××¨×× ××××× ××¡×

01/01/1995

××¡××¨×ª ××××× ××¡×

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 31.07.2011

×¢××× ××¦×¨××	Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×××¤×××§×¡×¦×× × ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	B.BRAUN MEDICAL S.A., SPAIN
×©× ××¢× ××¨××©××	BIOAVENIR LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 01/2004. ×¨××©××× ××ª××¨××: 01/2015
×ª××¨×× ×¢×××× ×××¨××	14/05/19

↑חזרה לקטע הקודם

אופלוקסצינה - Ofloxacina

× ×ª×× × ×¡× [ ××¦×× ]

ויקיתרופות

× ×ª×× × ×¡× [ ××¦×× ]